The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Virax Biolabs Group Limited(NASDAQ:VRAX) 
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, anti...
Website: https://viraxbiolabs.com
Founded: 2021
IPO Price: $5 (Jul 21, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Virax Biolabs Group Days Payable Outstanding ttm (DPO)
Virax Biolabs Group Days Receivable Outstanding ttm (DSO)
Virax Biolabs Group Days Inventory Outstanding ttm (DIO)
Virax Biolabs Group Op Cashflow Per Share ttm
Virax Biolabs Group Free Cashflow Per Share ttm
Virax Biolabs Group Cash Per Share ttm
Virax Biolabs Group P/S ratio ttm
Virax Biolabs Group (GAAP) P/E ratio ttm
Virax Biolabs Group P/B ratio ttm
No extra charts and metrics for this ticker.